LLY ELI LILLY & Co
- Stocks
- Healthcare
- NYSE: LLY
Price (delayed)
$639.43
Market cap
$605.19B
P/E Ratio
41.66
Dividend/share
$5.6
EPS
$15.35
Enterprise value
$641.72B
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded
Highlights
The EPS has soared by 88% YoY and by 24% QoQ
The net income has soared by 88% YoY and by 24% from the previous quarter
ELI LILLY's debt has increased by 38% YoY and by 3.6% from the previous quarter
The quick ratio has declined by 13% year-on-year and by 7% since the previous quarter
Key stats
What are the main financial stats of LLY
Market
Valuations
Earnings
Shares outstanding
946.46M
Market cap
$605.19B
Enterprise value
$641.72B
Price to earnings (P/E)
41.66
Price to book (P/B)
33.16
Price to sales (P/S)
10.78
EV/EBIT
38.06
EV/EBITDA
34.22
EV/Sales
12.05
Revenue
$53.26B
Gross profit
$44.01B
Operating income
$16.86B
Net income
$13.8B
EBIT
$16.86B
EBITDA
$18.75B
Free cash flow
$4.88B
Per share
Balance sheet
Liquidity
EPS
$15.35
EPS diluted
$15.3
Free cash flow per share
$5.44
Book value per share
$19.28
Revenue per share
$59.31
TBVPS
$99.39
Total assets
$100.92B
Total liabilities
$82.57B
Debt
$39.9B
Equity
$18.27B
Working capital
$10.83B
Debt to equity
2.18
Current ratio
1.28
Quick ratio
0.53
Net debt/EBITDA
1.95
Margins
Efficiency
Dividend
EBITDA margin
35.2%
Gross margin
82.6%
Net margin
25.9%
Operating margin
31.7%
Return on assets
16%
Return on equity
88.4%
Return on invested capital
22.1%
Return on capital employed
27.2%
Return on sales
31.7%
Dividend yield
0.88%
DPS
$5.6
Payout ratio
36.5%
LLY stock price
How has the ELI LILLY stock price performed over time
Intraday
0.66%
1 week
-16.52%
1 month
-19.37%
1 year
-27.7%
YTD
-17.17%
QTD
-17.97%
Financial performance
How have ELI LILLY's revenue and profit performed over time
Revenue
$53.26B
Gross profit
$44.01B
Operating income
$16.86B
Net income
$13.8B
Gross margin
82.6%
Net margin
25.9%
LLY's operating income has surged by 88% year-on-year and by 24% since the previous quarter
The net income has soared by 88% YoY and by 24% from the previous quarter
The company's gross profit rose by 40% YoY and by 10% QoQ
ELI LILLY's net margin has increased by 37% YoY and by 14% from the previous quarter
Price vs fundamentals
How does LLY's price correlate with its fundamentals
Growth
What is ELI LILLY's growth rate over time
Valuation
What is ELI LILLY stock price valuation
P/E
41.66
P/B
33.16
P/S
10.78
EV/EBIT
38.06
EV/EBITDA
34.22
EV/Sales
12.05
The EPS has soared by 88% YoY and by 24% QoQ
The P/E is 40% below the last 4 quarters average of 69.7 and 31% below the 5-year quarterly average of 60.3
The equity has increased by 35% year-on-year and by 16% since the previous quarter
LLY's P/B is 34% below its last 4 quarters average of 50.2 and 16% below its 5-year quarterly average of 39.6
ELI LILLY's revenue has increased by 37% YoY and by 9% from the previous quarter
The stock's price to sales (P/S) is 32% less than its last 4 quarters average of 15.8 and 11% less than its 5-year quarterly average of 12.1
Efficiency
How efficient is ELI LILLY business performance
The company's return on equity rose by 46% YoY and by 15% QoQ
The ROA has grown by 40% YoY and by 13% from the previous quarter
The ROS has increased by 37% YoY and by 14% QoQ
The ROIC has grown by 26% YoY and by 12% from the previous quarter
Dividends
What is LLY's dividend history
DPS
$5.6
Dividend yield
0.88%
Payout ratio
36.5%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did ELI LILLY financials performed over time
LLY's total assets is 22% greater than its total liabilities
ELI LILLY's total liabilities has increased by 42% YoY and by 12% from the previous quarter
LLY's total assets is up by 40% year-on-year and by 13% since the previous quarter
ELI LILLY's debt is 118% more than its equity
ELI LILLY's debt has increased by 38% YoY and by 3.6% from the previous quarter
The equity has increased by 35% year-on-year and by 16% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.